Skip to main content

DCVC — Portfolio, Page 9

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

286
Companies
$4.9B
Total invested
$27.4M
Avg. check
51
Industries
Biotechnology 7Software 6Health Care 4Life Science 4Medical 4Artificial Intelligence (AI) 4+45 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 193216 of 286
Superfluid Dx
December 2023

Superfluid Dx is a biotechnology company developing novel blood-based early detection.

Biotechnology · San DiegoSeries A
Totus Medicines
December 2023

Totus Medicines employs uses AI/ML and innovative DNA-encoded covalent library tech to discover small molecule medicines.

Biopharma · Cambridge$66.0M Series B
Copia Global
December 2023

Copia Global provides a consumer catalog order and delivery system intended to serve consumers in the developing world.

Consumer Goods · Nairobi$20.0M Series C
Thistle Technologies
November 2023

Thistle Technologies is building tools that help connected device manufacturers build security resiliency into devices.

Internet of Things · San Francisco$6.7M Seed
Aclarity
November 2023

Aclarity is a VC-backed cleantech startup developing and selling water treatment systems to clean the world's water and wastewater.

Information Technology · Hadley$15.9M Series A
Charlie
October 2023

Charlie provides financial and banking services to retirees.

Banking · Los Angeles$16.0M Series A
Radionetics Oncology
August 2023

Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.

Health Care · California City$52.5M Series A
Plotlogic
July 2023

Plotlogic utilizes an AI and sensor-driven platform to enhance yield in the critical mineral industry.

Analytics · Red Hill$28.0M Series B
Semantic Health
July 2023

AI-Powered Concurrent Coding and Auditing Platform

Health Care · TorontoDebt Financing
Ascend Gene & Cell Therapies
May 2023

Ascend Gene & Cell Therapies is a model for gene and cell therapy manufacturing.

Biotechnology · Potters Bar$65.9M Series A
Data Robot (Formerly Agnostiq)
April 2023

Agnostiq is the company behind Covalent, a fully Pythonic, serverless compute engine for AI/ML/HPC. Learn more at www.covalent.xyz

Artificial Intelligence (AI) · Toronto$9.1M Seed
Empirico
March 2023

Empirico is a developer of an insights platform designed to turn biological insights from human genetics into new medicines.

Biotechnology · San Diego$45.2M Series B
Shennon Biotechnologies
March 2023

ShennonBio analyzes and manipulates a massive number of cells on the single cell level to develop better treatments for human diseases.

Biotechnology · San Francisco$13.0M Seed
Aquafortus
February 2023

Aquafortus is a non-thermal recovery and crystallization technology platform.

Consulting · Mangere$17.0M Series A
Nest Genomics (YC W22)
January 2023

Nest Genomics is a lab-agnostic, comprehensive software solution for implementing genomic programs at scale.

Health Care · New York$8.5M Seed
MosaicML
January 2023

MosaicML builds an efficient infrastructure for training language models.

Artificial Intelligence (AI) · San FranciscoSeries Unknown
Braavos
October 2022

Braavos is a smart contract based wallet for managing your funds & NFTs and connecting to dApps.

Bitcoin · Tel Aviv$10.0M Seed
Novome Biotechnologies
September 2022

Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.

Biopharma · South San Francisco$43.5M Series B
Verdant Robotics, Inc.
August 2022

Verdant builds AI-powered Smart Sprayers that weed, thin, fertilize & deliver nutrients at millimeter level.

Agriculture · Hayward$46.5M Series A
Rill Data
August 2022

Rill Data is a simple alternative to complex BI stacks—the fastest, easiest path from data to metrics dashboards.

Analytics · San Francisco$12.0M Seed
Petra
June 2022

Petra is a Robotics company that focuses solely on underground utilities.

Civil Engineering · San FranciscoSeries Unknown
Fletch
April 2022

Fletch provides ready-to-use analytics organized in solutions sets that are easy to understand and actionable on day one.

Analytics · San Francisco$12.6M Series A
zkLend
March 2022

zkLend is an L2 money-market protocol built on StarkNet, combining zk-rollup scalability, superior transaction speed, and cost-savings.

Cryptocurrency · Hong Kong$5.0M Seed
Creyon Bio
March 2022

Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.

Biotechnology · San Diego$40.0M Series A

Where DCVC invests

Biotechnology7
Software6
Health Care4
Life Science4
Medical4
Artificial Intelligence (AI)4

About DCVC's portfolio

How many companies has DCVC invested in?

DCVC has invested in 286 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does DCVC invest in?

DCVC's top investment sectors include Biotechnology, Software, Health Care, Life Science, Medical. The firm invests across 51 different industry categories.

What is DCVC's largest investment?

Among tracked funding rounds, Totus Medicines received $66.0M in a Series B round. DCVC's total known invested capital is $4.9B.

What is the average investment size for DCVC?

DCVC's average investment size is $27.4M across its portfolio of 286 companies.

What are DCVC's most recent investments?

Recent DCVC portfolio additions include Superfluid Dx, Totus Medicines, Copia Global, Thistle Technologies, Aclarity. These companies were founded in 2020 or later.

Reach the founders behind these 286 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →